Most content about substances falls into two camps: pretend they don't exist, or pretend supplements can make them safe. Neither is useful to the millions of thoughtful adults who drink, use cannabis, occasionally roll, try ketamine, or work with psychedelics intentionally.
This guide is for those people. It's an evidence-tiered look at what the research actually shows about protecting your health when you use substances — including where the evidence is strong, where it's weak, and where the supplement industry is selling you noise.
The ground rules of harm reduction
Before any supplement discussion, four foundational interventions cut risk more than any ingredient will. These come first in every protocol on this site.
1. Test your substances
If you use a powder substance you didn't manufacture yourself, you don't know what's in it. This has always been true, but it's more dangerous now. Fentanyl contamination in the US drug supply has increased dramatically over the past five years, appearing in MDMA, cocaine, and ketamine samples far more than most recreational users realize.
The evidence (established): Fentanyl test strips and reagent test kits (Marquis, Mecke, Ehrlich) are cheap, accurate, and the single highest-impact thing you can do. DanceSafe distributes them at events; many US cities have fixed-site drug checking services. The evidence base for testing as harm reduction is strong and not controversial.
2. Dose control
Start low, weigh doses, and know the difference between threshold, light, common, strong, and heavy ranges. Tripsit.me maintains the clearest dose charts for most substances. Lower your dose if you are smaller than average, if it's a first experience with a given batch, if you're combining substances, or if your sleep or nutrition is compromised.
3. Set and setting
The psychedelic research literature has validated "set and setting" — your mindset and environment — as decisive determinants of outcome. This applies beyond psychedelics. Using substances to escape acute distress tends to amplify it; using them with trusted people in a safe environment tends to produce better experiences and lower risk.
4. Timing and spacing
For every substance, there's a frequency above which protective interventions can't keep up with the damage.
Key takeaway: MDMA: 6-12 weeks minimum between experiences. Ketamine: recreational use should stay below weekly frequency; daily use has well-documented bladder consequences. Alcohol: at least three alcohol-free days per week is the lightest-touch floor. Classic psychedelics: 1-2 weeks for serotonin receptor reset.
MDMA: what the evidence supports
MDMA (ecstasy) causes massive serotonin release followed by reuptake inhibition, creating a period of serotonergic oxidative stress. In animal models at high or repeated doses, this produces measurable axonal damage to serotonin neurons. Human evidence of lasting cognitive and mood effects in heavy users is more debated, but the directional signal is real.
The neuroprotection story is built on antioxidant intervention during the acute oxidative stress window.
Pre-session: the evidence-backed stack
The evidence (emerging): Alpha-lipoic acid (ALA), N-acetylcysteine (NAC), acetyl-L-carnitine (ALCAR), and vitamin C have the best data across animal MDMA neurotoxicity studies. Human RCT data is limited. Mechanism is well-established: these ingredients raise glutathione, reduce reactive oxygen species, and support mitochondrial function during the acute challenge.
A commonly cited protocol, adapted from published rat studies (Aguirre et al., 1999; Shankaran et al., 2001):
- 3 hours before: 500mg ALCAR + 500mg vitamin C
- 1 hour before: 2g ginger (for nausea), optional 100mg magnesium
- With MDMA: 300mg ALA, 500mg vitamin C
- +1 hour: 300mg ALA, 500mg ALCAR
- +2 hours: 300mg ALA
- +3 to +7 hours: 300mg ALA hourly (total daily cap: 2,400mg)
- +5 hours: 500mg ALCAR
- Before sleep: melatonin (0.5-3mg)
A few notes the supplement industry won't tell you. First, all of the human-relevant efficacy data for these compounds in MDMA contexts is preclinical. Second, the doses are extrapolated from animal studies. Third, the product category ("MDMA supplements") exists in a regulatory gray zone — none of these products carry FDA approval for this use.
Post-session: restoration
The post-session phase supports serotonin system recovery. This is where 5-HTP enters — but not before 48 hours after the MDMA experience.
When to see a doctor
Taking 5-HTP within 48 hours of MDMA can cause serotonin syndrome — confusion, high fever, muscle rigidity, irregular heartbeat. This is life-threatening. Wait 48 hours minimum.
After 48 hours: - 5-HTP 100-400mg daily with B6, for 2 weeks - NAC 600-1200mg daily - Omega-3 (EPA/DHA) 1-2g daily - Tryptophan-rich foods (eggs, oats, turkey) — safer and self-regulated than high-dose 5-HTP
What doesn't work
"Rolling caps" sold at festivals are generally not third-party tested and rarely match their label. Grapefruit juice "boosting" isn't harm reduction — it increases blood levels and risk. And no supplement can make MDMA safe for people on SSRIs, MAOIs, or tramadol.
Alcohol: the category with the most noise
Alcohol is the single most-used substance in harm reduction populations, and the supplement category around it is riddled with products that don't work.
What the RCTs actually show
A 2021 peer-reviewed analysis of 82 hangover products on the US market found that none had double-blind, placebo-controlled human evidence for their claims. A 2025 follow-up analysis of 46 products reached the same conclusion.
More damning: the two most-marketed hangover ingredients, dihydromyricetin (DHM) and N-acetylcysteine (NAC), have now failed in placebo-controlled human trials.
- NAC: Podobnik et al., 2024, found no effect on hangover severity.
- DHM: Verster et al., 2021 and Lee et al., 2024 — also no effect.
The evidence (preclinical): DHM's GABA-A receptor modulation and liver-protective effects are real in animal models. The acute hangover claim, though, is not supported by human RCTs. Same for NAC as a hangover intervention. If you see marketing that says DHM "prevents hangovers," it is not consistent with the current human evidence.
What might actually help
If you drink regularly, there are supplements with real evidence for the long-term consequences of alcohol — even if the acute hangover claim is weak.
The evidence (established): - Thiamine (vitamin B1) 50-100mg daily. Alcohol depletes thiamine, and heavy drinkers are at risk of Wernicke's encephalopathy. This is uncontroversial and covered in every clinical guideline. - Omega-3 (EPA/DHA) 1-2g daily. Counteracts alcohol-induced neuroinflammation; helps cognition and mood. - Vitamin D 2,000 IU. Deficiency is common and worsens mood and immune function. - Magnesium glycinate 200-400mg. Consistently depleted by alcohol. - Folate + B12 (methylated forms).
The lifestyle interventions that beat any supplement
- Three or more alcohol-free nights per week
- 7+ hours of sleep on drinking nights
- Proper hydration and electrolytes (not just water — sodium and potassium matter)
- Protein-and-fat meal before drinking slows absorption
- Don't combine with other CNS depressants
When to see a doctor
If you experience tremor, sweating, or anxiety when you stop drinking; if you black out; if you drink to manage anxiety or sleep; or if your weekly intake exceeds 14 drinks (men) or 7 drinks (women), talk to a physician. Alcohol withdrawal can be medically dangerous and should be managed clinically.
Ketamine: the most urgent risk most users don't know about
Ketamine gets marketed in wellness circles as the gentle introduction to dissociative psychedelic experiences. For occasional users with no underlying issues, that's roughly accurate. But there's a specific risk profile with ketamine that the psychedelic wellness world systematically underdiscusses: ketamine-induced cystitis, or "ketamine bladder."
What the urology literature says
Ketamine metabolites excreted in urine cause inflammation and, with continued use, structural damage to the bladder wall. The BAUS (British Association of Urological Surgeons) 2024 consensus statement establishes a three-stage progression:
- Stage 1: Inflammatory phase. Reversible with cessation.
- Stage 2: Structural changes — reduced bladder capacity, thickening of bladder wall.
- Stage 3: Fibrosis, ureter obstruction, possible kidney involvement. Often irreversible.
Around 25% of regular recreational ketamine users develop urinary symptoms. Among users who take ketamine three or more times per week, that number approaches 50%.
When to see a doctor
If you use ketamine and experience any of the following, see a urologist promptly: urinary urgency (needing to go more than once an hour), bladder or pelvic pain, painful urination, blood in urine, or pain in your flanks. These are not minor symptoms. Early intervention can prevent permanent damage.
What the supplement evidence shows
For occasional users without symptoms, the post-session protocol is modest:
The evidence (emerging): - Taurine 500-600mg (NMDA modulation) - NAC 600mg (glutathione, antioxidant) - Magnesium glycinate 200-400mg (NMDA antagonism, sleep) - EGCG 250mg (antioxidant) - B-vitamin complex with methylated forms
For frequent users or those with symptoms, the only intervention with strong evidence is cessation. No supplement on the market has been shown in controlled trials to prevent or reverse ketamine bladder damage.
The honest answer for heavy users
If you're using ketamine more than weekly, the harm reduction conversation is different from the one about MDMA or alcohol. The bladder damage is specific to ketamine, potentially permanent, and unrelated to whether you protect yourself nutritionally. Reducing frequency is the intervention. No product can substitute for that.
Cocaine and stimulants: the most dangerous mixing problem
Most cocaine users don't know about cocaethylene.
When cocaine and alcohol are metabolized together in the liver, they form cocaethylene — a metabolite that's more cardiotoxic than either parent substance and has a significantly longer half-life. Cocaethylene multiplies cardiovascular risk and is documented as a substantial contributor to young-adult stroke and heart attack events.
The evidence (established): The cocaethylene literature is strong and uncontroversial across cardiology and toxicology. If you take one thing from this article about cocaine, it's that combining it with alcohol is substantially more dangerous than using either one alone — and that risk is invisible in the short term.
What supplements can and can't do
The supplement evidence for stimulant harm reduction is thin. Most research focuses on treating stimulant use disorder, not protecting recreational users. Be wary of anything marketed as "stimulant recovery stack" — the evidence is weak.
The evidence (emerging): NAC has the strongest evidence in this category. RCTs in cocaine use disorder have shown reduced craving and some oxidative stress marker improvements. Typical dose: 1,200-2,400mg daily. Evidence for casual users is extrapolated and not well-studied.
Other supplements sometimes used: - Magnesium 300-400mg (arterial support) - Omega-3 2g daily (anti-inflammatory) - L-Tyrosine 500-1,000mg (dopamine precursor, post-use cognitive recovery) - B-complex with methylated forms - Vitamin C 500-1,000mg (antioxidant)
None of these are a substitute for the primary intervention, which is either cessation or (at minimum) not combining cocaine with alcohol.
When to see a doctor
Chest pain, severe headache, numbness or weakness on one side, sustained elevated heart rate (>130), or very high blood pressure during or after stimulant use are medical emergencies. Do not wait.
Classic psychedelics: psilocybin, LSD, DMT
The physiological safety profile of classic psychedelics at typical doses is actually quite favorable — no dependence liability, minimal cardiotoxicity. The risks are psychological: challenging experiences, hallucinogen persisting perception disorder (HPPD), and risk of triggering prolonged psychosis in vulnerable individuals.
Who should not use psychedelics
Personal or family history of schizophrenia, schizoaffective disorder, or bipolar I disorder is a contraindication. The evidence here is strong and the risk of triggering a prolonged episode is real.
Medication interactions
- SSRIs/SNRIs: blunt effects significantly; MDMA interaction is more concerning (theoretical serotonin syndrome plus attenuated effect)
- MAOIs: significant interaction; inherent in ayahuasca; dangerous with most other substances
- Lithium: increased seizure risk with classic psychedelics — do not combine
- Tricyclics: amplify effects unpredictably
Preparation and integration
This is where the strongest evidence in the psychedelic literature actually sits. Kishon and Cycowicz's 2025 review in Frontiers in Psychiatry synthesizes the research on preparation and integration as decisive determinants of outcome.
Preparation matters more than any supplement: - Clear intention for the experience - Adequate sleep, nutrition, sobriety in the days prior - Trusted companions and safe environment - Understanding of what to expect
Integration matters even more: - Structured reflection sessions in the 1-4 weeks after - Journaling, creative expression, contemplative practice - Behavioral changes tied to insights - Community or professional support where appropriate
The evidence (established): The evidence for integration as a therapeutic amplifier is among the strongest in the entire psychedelic literature. A supplement stack is far less important than whether you do the work after.
Minimal supplement support
- Omega-3 for general neural health during the neuroplasticity window
- Vitamin D (commonly deficient, supports serotonin system)
- Magnesium for sleep and stress during integration
- Lion's mane (popular in the "Stamets stack"; human cognitive evidence is weak but safety is good)
What to avoid: niacin flushing protocols (no mechanistic benefit), tryptamine-boosting supplements on the day (5-HTP, St. John's wort), and lithium orotate (explicit seizure contraindication).
Cannabis: underappreciated risks
For occasional users, cannabis is generally low-risk — with one exception that generates a disproportionate number of ER visits: edible overdose. Start at 2.5mg THC, wait two hours, and respect that edibles have an onset-delay that tricks people into redosing.
For daily users, the concerns are different. Tolerance develops fast; cannabinoid hyperemesis syndrome is emerging in heavy chronic users; sleep architecture is disrupted; and regular use under age 25 may affect brain development.
The single highest-impact intervention
Tolerance breaks. Hirvonen et al.'s 2012 PET imaging study showed that CB1 receptor resensitization occurs over approximately 21 days of abstinence. Shorter breaks help less; longer breaks help more.
Peptides: the emerging frontier (with caveats)
A growing wellness interest in "nootropic peptides" — Semax, Selank, Cerebrolysin, BPC-157 — deserves honest treatment. The evidence landscape is more complex than either the vendor marketing or the skeptics would have it.
The evidence (emerging): Cerebrolysin has the deepest evidence base — 200+ clinical trials, ~15,000 patients across 40+ countries approved for Alzheimer's, TBI, and stroke. Not FDA-approved in the US.
Semax and Selank have meaningful Russian clinical literature but limited US-standard trials. Both require injection or nasal administration.
BPC-157 has popular use but the human data is minimal.
None of these are legal US supplements. They're research chemicals in the US, and the vendor ecosystem is unregulated.
For a deeper treatment of which peptides have real data and which don't, see our detailed peptide evidence review.
The supplement framework: what to prioritize
If you're going to spend money on supplements to support substance use, priority order based on the evidence:
- Sleep support — magnesium glycinate, L-theanine at night. Sleep is the single most underrated recovery tool.
- Omega-3 (EPA/DHA) 2g daily — broadest evidence base; helps with alcohol, cannabis, and general neuroinflammation.
- B-complex with methylated forms — critical for heavy drinkers; supports neurotransmitter synthesis.
- Vitamin D3 — commonly deficient, supports serotonin system.
- Substance-specific pre/post protocols — MDMA antioxidant stack, post-ketamine restoration, etc.
What you probably don't need: - Mega-dose vitamin C products - Generic "detox" supplements - Proprietary blends without disclosed dosing - Anything marketed as an "instant hangover cure" - Activated charcoal for alcohol (doesn't work)
The lifestyle layer
No supplement stack compensates for fundamentals:
- Sleep: 7-9 hours, consistent schedule, dark environment
- Protein: 1.6-2.2g per kg bodyweight for people who exercise
- Exercise: zone 2 cardio 3x/week + resistance training 2x/week (BDNF elevation is well-documented and more reliable than any supplement)
- Light exposure: morning sunlight for circadian entrainment
- Integration practices: journaling, therapy, community
- Honest community: destigmatized conversations about use
When supplements aren't the answer
Supplements are harm reduction, not harm elimination. Some patterns need clinical care, not a protocol.
When to see a doctor
If you experience: - Withdrawal symptoms when stopping any substance - Suicidal ideation - Psychotic symptoms - Bladder pain or blood in urine (ketamine users) - Chest pain or neurological symptoms during/after stimulant use - Significant dependency concerns - Worsening mood or cognition despite your protocol
See a physician. Explorer Health's content is educational; it is not a substitute for medical care.
Your next step
If you've read this far, you're the kind of person Explorer Health was built for — someone who wants the actual evidence, not the marketing gloss.
The next useful thing you can do is take our 5-minute brain health quiz. It uses the frameworks in this article to generate a personalized profile based on your specific pattern and goals. It's free. No judgment. No sales pitch for products you don't need.
**Take the Explorer Health Quiz →**
---
Frequently Asked Questions
Are harm reduction supplements a substitute for not using substances?
No. The safest option for any substance is abstinence or medical supervision. Harm reduction supplements support the body's response to substances you're going to use anyway. They don't neutralize the risks, and they don't make any illegal substance safe or legal.
Which harm reduction supplement has the strongest evidence?
The strongest-evidence individual interventions are generally not branded "harm reduction" products. Thiamine for heavy drinkers, omega-3 for inflammation, magnesium for sleep, and vitamin D for general neural health all have robust human RCTs. Substance-specific protocols (like the MDMA antioxidant stack) rest on strong mechanistic evidence with less human RCT data.
Do DHM and NAC actually prevent hangovers?
No. Both have now failed in placebo-controlled human trials (Podobnik et al. 2024 for NAC; Verster et al. 2021 and Lee et al. 2024 for DHM). They may have other benefits — GABA-A modulation, glutathione support — but the specific claim of preventing or reducing hangover severity is not supported by human RCTs.
Is it safe to take 5-HTP with MDMA?
No, not on the same day. Taking 5-HTP within 48 hours of MDMA can cause serotonin syndrome, a potentially fatal condition. The standard protocol waits 48 hours after MDMA before starting 5-HTP, then uses 100-400mg daily for about two weeks to support serotonin system recovery.
Does any supplement prevent ketamine bladder?
No supplement has been shown in controlled trials to prevent ketamine-induced cystitis. The intervention is frequency reduction. Users taking ketamine more than weekly should understand that bladder damage becomes more likely and potentially irreversible with continued use.
What's the most important thing for someone using psychedelics?
Set and setting preparation and post-experience integration. The evidence for integration as a therapeutic amplifier is among the strongest in the psychedelic literature. A supplement stack is less important than whether you do the reflective work after.
Are "peptides" like Semax and Cerebrolysin worth trying?
Cerebrolysin has real clinical evidence (200+ trials, approved in 40+ countries, though not in the US). Semax and Selank have meaningful but mostly Russian literature. None are legal US supplements, and the vendor ecosystem is unregulated — purity and dose accuracy are real problems. For most people, the cost-benefit isn't favorable at this point.
Should I take daily antioxidant supplements if I drink regularly?
Omega-3 (EPA/DHA), vitamin D, a B-complex with methylated forms, and magnesium have the best evidence for regular drinkers. Mega-dose vitamin E, vitamin C "bombs," and most "liver cleanse" products have weak or no evidence behind their claims.
---
References and citations
References
- Aguirre N, Barrionuevo M, Ramírez MJ, Del Río J, Lasheras B. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport. 1999;10(17):3675-80.
- Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse. 2001;40(1):55-64.
- Verster JC, van Rossum CJI, Scholey A. Unknown safety and efficacy of alcohol hangover treatments puts consumers at risk. Addictive Behaviors. 2021;122:107029. [PMID: 34225031]
- Podobnik J, Vuica-Ross M, Lovrić M, et al. N-acetylcysteine for hangover prevention: a randomized controlled trial. 2024.
- Lee HS, Yoon SA, Kim MY, et al. Effects of dihydromyricetin on alcohol hangover symptoms: a double-blind RCT. 2024.
- Shen Y, Lindemeyer AK, Gonzalez C, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci. 2012;32(1):390-401. [PMC3292407]
- Belal M, et al. British Association of Urological Surgeons Consensus Statements on the management of ketamine uropathy. BJU International. 2024.
- Jhang JF, Hsu YH, Kuo HC. Ketamine-induced cystitis: a comprehensive review. PMC9476224. 2023.
- Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 2012;110(11):1762-6.
- Kishon R, Cycowicz YM. Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes. Frontiers in Psychiatry. 2025;16:1637162.
- Pettorruso M, Miuli A, Clemente K, et al. Enhanced peripheral levels of BDNF and proBDNF in cocaine use disorder. Molecular Psychiatry. 2024;29:760-766.
- Hirvonen J, Goodwin RS, Li CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry. 2012;17(6):642-9.
- Plosker GL, Gauthier S. Cerebrolysin: a review of its use in dementia. Drugs & Aging. 2009;26(11):893-915.
- Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46.
- US Food and Drug Administration. Dietary Supplements: Structure/Function Claims. [Regulatory guidance.]
---
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Statements have not been evaluated by the FDA. Products discussed are not intended to diagnose, treat, cure, or prevent any disease. Explorer Health does not condone illegal substance use. If you are in crisis, call or text 988 (US) or go to your nearest emergency room.